Digital Detection of Sarcoma Fusion Genes
|SPEAKER:||Tony Ng MD, PhD, FRCPC, Consultant Pathologist BCCA and Vancouver General Hospital|
Jan 17, 2018
Digital detection of nucleic acids is rapidly empowering molecular characterization of challenging diseases such as non-small cell lung cancer and sarcoma. With its high specificity and reproducibility, the nanoString platform is capable of measuring RNA and DNA counts from highly degraded samples using only 150ng of FFPE-extracted RNA and only 5ng of DNA for quantitation of features of interest. This session will explore how groups working to analyze blood-based mRNA signatures have achieved success on the nanoString nCounter platform.